Anemia of cancer improving/prophylactic agent
AssigneeSBI Pharmaceuticals Co., Ltd.
InventorsTohru Tanaka, Motowo Nakajima, Fuminori Abe, Satofumi Kawata, Kiwamu Takahashi
Life of this patent
Estimating the term…
Abstract
A method for ameliorating and/or preventing cancerous anemia includes administering to a subject in need thereof an agent containing 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt thereof. Preferably, these ALAs contain a metal-containing compound, such as sodium ferrous citrate. The above-mentioned ALAs, ALA; various esters such as ALA methylester, ALA ethylester, ALA propylester, ALA butylester, and ALA pentylester; and hydrochlorides, phosphates, and sulfates, and the like of these ALA esters are preferred examples.
Claims10
A method for ameliorating and/or preventing cancerous anemia, the method comprising administering to a subject having cancerous anemia an agent comprising a compound represented by the following formula (I) or a salt thereof:
- wherein R1 and R2 are hydrogen atoms, and
- wherein the subject is a patient with cancer who is characterized by both reduction of red blood cells and reduction of at least one selected from lymphocytes, neutrophils, and blood platelets.
Dependencies are inferred from the claim text.